Susan Dorman, M.D., an infectious disease physician at the Medical University of South Carolina (MUSC), was recently awarded a 10-year, $9.9 million contract by the Centers for Disease Control and Prevention to run trials for the Tuberculosis Trials Consortium (TBTC).
The TBTC is a collaboration of researchers whose goal is to improve the diagnosis, management and prevention of tuberculosis (TB) around the world. Dorman, who has dedicated her career to studying the disease, serves as a TB medical consultant for the South Carolina Department of Health and Environmental Control and leads research efforts to improve TB treatment and prevention.
“In the U.S., we think of TB as a disease of the past, and we do have good TB control in this country,” Dorman explained. “However, in many other parts of the world, it is still a contemporary health problem that impacts people’s lives in terms of morbidity and mortality.”
According to the World Health Organization, TB is one of the top 10 leading causes of death in low-income countries. That’s why Dorman has a long-term collaboration with a research team at the University of Cape Town Lung Institute in South Africa, where TB is very common. For one of the TBTC projects, she will partner with the Cape Town team to test TB treatment interventions in an area where people are severely affected by the disease…